• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Clinical risk-stratification for prostate cancer: Where are we, and where do we need to go?前列腺癌的临床风险分层：我们现在处于什么位置，以及我们需要走向何方？
Can Urol Assoc J. 2017 Mar-Apr;11(3-4):101-102. doi: 10.5489/cuaj.4520.
2
Defining high risk prostate cancer--where do we set the bar? A translational science approach to risk stratification.定义高危前列腺癌——我们该如何设定标准？一种风险分层的转化科学方法。
J Urol. 2006 Dec;176(6 Pt 2):S21-4; discussion S25-6. doi: 10.1016/j.juro.2006.06.078.
3
Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.改善原发性前列腺癌诊断时的临床风险分层：一项预后建模研究。
PLoS Med. 2016 Aug 2;13(8):e1002063. doi: 10.1371/journal.pmed.1002063. eCollection 2016 Aug.
4
Novel concepts for risk stratification in prostate cancer.前列腺癌风险分层的新概念。
J Clin Urol. 2016 Dec;9(2 Suppl):18-23. doi: 10.1177/2051415816673502. Epub 2016 Dec 1.
5
Percentage of positive biopsy cores: a better risk stratification model for prostate cancer?阳性活检核心的百分比：前列腺癌更好的风险分层模型？
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1141-8. doi: 10.1016/j.ijrobp.2011.09.043. Epub 2011 Nov 16.
6
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer.前列腺癌有利的中间风险、不利的中间风险和极高风险分层标准的统一。
BJU Int. 2017 Nov;120(5B):E87-E95. doi: 10.1111/bju.13903. Epub 2017 Jun 3.
7
Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).使用活检前多参数磁共振成像（mpMRI）对前列腺癌侵袭性进行分层。
NMR Biomed. 2016 Mar;29(3):232-8. doi: 10.1002/nbm.3452. Epub 2016 Jan 5.
8
Risk stratification of prostate cancer in the modern era.现代前列腺癌的风险分层
Curr Opin Urol. 2015 May;25(3):246-51. doi: 10.1097/MOU.0000000000000164.
9
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis.高危前列腺癌的术前风险分层：一项多中心分析
Front Oncol. 2020 Mar 6;10:246. doi: 10.3389/fonc.2020.00246. eCollection 2020.
10
Risk stratification in oligometastatic prostate cancer: where are we and what do we need?寡转移前列腺癌的风险分层：我们目前的状况以及我们需要什么？
Curr Opin Urol. 2017 Nov;27(6):547-552. doi: 10.1097/MOU.0000000000000439.

引用本文的文献

1
Integrating Ga-PSMA-11 PET/CT with Clinical Risk Factors for Enhanced Prostate Cancer Progression Prediction.整合镓-PSMA-11 PET/CT与临床风险因素以增强前列腺癌进展预测
Cancers (Basel). 2025 Jul 9;17(14):2285. doi: 10.3390/cancers17142285.
2
Uncovering New Biomarkers for Prostate Cancer Through Proteomic and Network Analysis.通过蛋白质组学和网络分析发现前列腺癌的新生物标志物。
Biology (Basel). 2025 Mar 4;14(3):256. doi: 10.3390/biology14030256.
3
Do Dosiomic Features Extracted From Planned 3-Dimensional Dose Distribution Improve Biochemical Failure-Free Survival Prediction: an Analysis Based on a Large Multi-Institutional Data Set.从计划的三维剂量分布中提取的剂量学特征能否改善无生化失败生存预测：基于大型多机构数据集的分析
Adv Radiat Oncol. 2023 Mar 27;8(5):101227. doi: 10.1016/j.adro.2023.101227. eCollection 2023 Sep-Oct.
4
Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers.放疗诱导前列腺癌患者的固有免疫反应。
Clin Cancer Res. 2023 Mar 1;29(5):921-929. doi: 10.1158/1078-0432.CCR-22-2340.
5
Deep Neural Networks Outperform the CAPRA Score in Predicting Biochemical Recurrence After Prostatectomy.在预测前列腺切除术后生化复发方面，深度神经网络优于CAPRA评分。
Front Oncol. 2021 Feb 11;10:607923. doi: 10.3389/fonc.2020.607923. eCollection 2020.
6
A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence.一个包含关键 TET2 相关基因的 38 基因模型在预测生化复发方面对高危前列腺癌病例具有附加效用。
BMC Cancer. 2020 Oct 2;20(1):953. doi: 10.1186/s12885-020-07438-4.

本文引用的文献

1
The CAPRA Score at 10 Years: Contemporary Perspectives and Analysis of Supporting Studies.CAPRA 评分 10 年回顾：支持性研究的当代观点与分析。
Eur Urol. 2017 May;71(5):705-709. doi: 10.1016/j.eururo.2016.08.065. Epub 2016 Sep 8.
2
Analysis of the Cancer of the Prostate Risk Assessment to predict for biochemical failure after external beam radiotherapy or prostate seed brachytherapy.前列腺癌风险评估分析，用于预测外照射放疗或前列腺粒子近距离放疗后的生化复发。
Urology. 2014 Sep;84(3):629-33. doi: 10.1016/j.urology.2014.05.032.
3
The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapy.前列腺癌风险评估 (CAPRA) 评分可预测接受外照射放疗 (EBRT) 剂量递增或低剂量率 (LDR) 近距离放疗的中危前列腺癌的生化复发。
BJU Int. 2014 Dec;114(6):865-71. doi: 10.1111/bju.12587. Epub 2014 Mar 14.
4
Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease.临床分期对当代局限性前列腺癌患者预后的影响较小。
J Urol. 2010 Jul;184(1):114-9. doi: 10.1016/j.juro.2010.03.025. Epub 2010 May 15.
5
Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.接受初始雄激素剥夺治疗的前列腺癌患者的风险评估。
J Clin Oncol. 2009 Sep 10;27(26):4306-13. doi: 10.1200/JCO.2008.21.5228. Epub 2009 Aug 10.
6
An updated catalog of prostate cancer predictive tools.前列腺癌预测工具的最新目录。
Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908.
7
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.对于临床局限性前列腺癌男性患者，在接受或未接受激素治疗的情况下，定义放疗后的生化复发：美国放射肿瘤学组（RTOG）-美国放射肿瘤学会（ASTRO）凤凰城共识会议的建议
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74. doi: 10.1016/j.ijrobp.2006.04.029.
8
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.用于预测局限性前列腺癌三维适形放疗后5年转移概率的治疗前列线图。
J Clin Oncol. 2003 Dec 15;21(24):4568-71. doi: 10.1200/JCO.2003.05.046.
9
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.临床局限性前列腺癌行根治性前列腺切除术、外照射放疗或近距离放疗后的生化结果。
JAMA. 1998 Sep 16;280(11):969-74. doi: 10.1001/jama.280.11.969.
10
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.前列腺癌根治性前列腺切除术后疾病复发的术前列线图。
J Natl Cancer Inst. 1998 May 20;90(10):766-71. doi: 10.1093/jnci/90.10.766.

Clinical risk-stratification for prostate cancer: Where are we, and where do we need to go?

作者信息

Cooperberg Matthew R

机构信息

Departments of Urology and Epidemiology & Biostatistics, UCSF Helen Diller Family Comprehensive Cancer Centre, University of California, San Francisco, CA, United States.

出版信息

Can Urol Assoc J. 2017 Mar-Apr;11(3-4):101-102. doi: 10.5489/cuaj.4520.

DOI:10.5489/cuaj.4520
PMID:28515808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5434505/
Abstract
摘要